1. P1078: PATIENTS WITH HODGKIN LYMPHOMA DEVELOP ADEQUATE HUMORAL SEROLOGICAL RESPONSE TO VACCINATION WITH TWO DOSES OF BNT162B2 AND THEIR IGG ANTIBODY LEVELS MARKEDLY INCREASE AFTER A THIRD VACCINE DOSE. (23rd June 2022) Authors: Dann, E.; Inbar, T.; Mashiach, T.; Eisa, J.; Ringelstein-Harlev, S.; Horowitz, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 968 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1584: CELLULAR IMMUNE RESPONSE TO THE BNT162B2 VACCINE IN LYMPHOMA PATIENTS. (23rd June 2022) Authors: Gurion, R.; Rozovski, U.; Itchaki, G.; Gafter-Gvili, A.; Leibovitch, C.; Raanani, P.; Szwarcwort, M.; Taylor-Abigadol, M.; Dann, E.; Horesh, N.; Inbar, T.; Tzoran, I.; Lavi, N.; Bar Haim, E.; Cohen, H.; Slouzky, I.; Azoulay, T.; Karmona, M.; Ringelstein-Harlev, S.; Horowitz, N. A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗